Potassium Acetate Injection, Solution, Concentrate
Product Images NDC 65219-512

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Potassium Acetate (NDC 65219-512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fresenius Kabi Logo (Pot13 0000 01)

FDA Label Image

Package Label (Principal Display Panel – Potassium Acetate Injection, USP 50 mL Vial Label)

Potassium Acetate Injection, USP 100 mEq/50 mL (2 mEq/mL) concentrate for intravenous use. The label indicates it is a pharmacy bulk package not for direct infusion and must be diluted before use. It includes concentration and storage information, manufacturer Fresenius Kabi USA, LLC, and cautions for preparation and handling.*

FDA Label Image

Package Label (Principal Display Panel – Potassium Acetate Injection, USP 50 mL Tray Label)

Potassium Acetate Injection, USP 100 mEq/50 mL (2 mEq/mL) concentrate vial label by Fresenius Kabi USA, LLC. The label includes dosage strength, volume (50 mL), and warnings such as 'Pharmacy Bulk Package–Not for Direct Infusion' and 'Must be Diluted for Intravenous Use.' Additional text provides storage instructions, aseptic technique advisories, and a barcode with NDC 65219-512-50.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.